Interim guidance for use of 23-valent pneumococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak

This document provides interim guidance on which groups should be vaccinated with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) to prevent pneumococcal infections during the outbreak of novel influenza A(H1N1).

Read the rest here:
Interim guidance for use of 23-valent pneumococcal polysaccharide vaccine during novel influenza A (H1N1) outbreak